Iradimed (IRMD) Return on Capital Employed Growth (1y) (2015 - 2026)
Iradimed (IRMD) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 216.00 |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 112.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.00 |
| Mar 31, 2026 | 337.00 |
| Dec 31, 2025 | 72.00 |
| Sep 30, 2025 | 4.00 |
| Jun 30, 2025 | -131.00 |
| Mar 31, 2025 | -46.00 |
| Dec 31, 2024 | -225.00 |
| Sep 30, 2024 | 38.00 |
| Jun 30, 2024 | 183.00 |
| Mar 31, 2024 | 276.00 |
| Dec 31, 2023 | 615.00 |
| Sep 30, 2023 | 489.00 |
| Jun 30, 2023 | 468.00 |
| Mar 31, 2023 | 687.00 |
| Dec 31, 2022 | 783.00 |
| Sep 30, 2022 | 969.00 |
| Jun 30, 2022 | 1,230.00 |
| Mar 31, 2022 | 1,515.00 |
| Dec 31, 2021 | 1,445.00 |
| Sep 30, 2021 | 913.00 |